An observational study in Nasal Septum Deviation, Rhinoplasty and Induced Hypotension, sponsored by Kahramanmaras Sutcu Imam University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Kahramanmaras Sutcu Imam University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Hypotension with a site in Turkey — 34 open to participants now, 35 under way, none of them phase 3. Hypotension · Turkey.
Among the 96 studies in Hypotension with a site in Turkey, this one is the 53rd largest by enrollment of the 62 observational ones that give a count, is one of 24 that started in 2026, is one of 62 observational ones, and was the 79th registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →34 of the 96 studies in Hypotension with a site in Turkey are open now. Recruiting first, the newest first:
Kayseri City Hospital · Sites in Turkey
Ages 18+ · Women only
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Sites in Turkey
Ages 18+
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Ordu University · Sites in Turkey
Ages 18–40 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 24 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is below the median of 93 across 269 observational studies indexed under Hypotension.
Median enrollment 101 across the 34 interventional studies, 100 across the 62 observational. Of the 53 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 96 has an industry lead sponsor. The 10 most frequent:
Kahramanmaras Sutcu Imam University is the lead sponsor of 200 studies on the registry; 42 are open to participants now.
Kahramanmaras Sutcu Imam University has 4 studies filed under Hypotension — fewer than ten, so there is no comparison to draw.
17 of the studies in Hypotension with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07794852Istanbul UniversityDural Sac Area-Guided Spinal Anesthesia Dosing for TURP | 2026-11-24 |
| NCT05993481Konya City HospitalThe Noninvasive Blood Pressure Measurement Effect on the Hypotension | 2026-11-25 |
| NCT07539896Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalThe Role of Preoperative Internal Jugular Vein Collapsibility and Perfusion Index in Predicting Hypotension After Spinal Anesthesia in Elective Cesarean Sections: A Prospective Observational Study | 2026-11-25 |
| NCT05960604Recep Tayyip Erdogan UniversityPressure Recording Analytical Method Parameters and Their Relationship With Hypotension in Hypertensive Patients | 2026-12 |
| NCT07777159Ankara City Hospital BilkentCarotid Doppler Changes After Passive Leg Raising for Prediction of Post-Induction Hypotension in Gastrointestinal Tumor Surgery | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 96 studies in Hypotension with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective observational study aims to evaluate the neurological safety of controlled hypotension (Mean Arterial Pressure 50-65 mmHg) during elective rhinoplasty. The investigators will assess whether this standard intraoperative hypotensive strategy causes cellular stress by measuring serum Glial Fibrillary Acidic Protein (GFAP) levels and early postoperative cognitive changes using the Montreal Cognitive Assessment (MoCA) test.
Controlled hypotension is frequently utilized in rhinoplasty to minimize bleeding and improve the surgical field. However, the potential cellular stress on the brain due to reduced cerebral perfusion is not fully understood. This study will enroll 40 ASA I-II patients undergoing elective rhinoplasty under general anesthesia with sevoflurane. Blood samples will be drawn at baseline (after anesthesia induction) and 24 hours postoperatively to measure serum GFAP levels via ELISA. Cognitive functions will be evaluated simultaneously using the MoCA test. The primary objective is to determine the change in GFAP concentrations, and the secondary objective is to evaluate its correlation with early postoperative cognitive scores.
The study population consists of adult patients, aged 18 to 50 years, who are scheduled to undergo elective primary rhinoplasty or septorhinoplasty under general anesthesia at the Department of Otorhinolaryngology and Plastic Surgery, Kahramanmaras Sutcu Imam University Hospital. Patients will be selected from those with an American Society of Anesthesiologists (ASA) physical status of I or II, ensuring a healthy cohort without severe systemic diseases.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing elective rhinoplasty receiving standard intraoperative controlled hypotension (Target MAP: 50-65 mmHg) maintained with sevoflurane and remifentanil.
Procedure: Controlled Hypotension (Standard of Care)
Maintenance of Mean Arterial Pressure (MAP) between 50 and 65 mmHg during the surgical procedure to optimize the surgical field.
Change in Serum Glial Fibrillary Acidic Protein (GFAP) Level
GFAP is a biomarker of astrocyte stress and blood-brain barrier permeability. Measured via ELISA (pg/mL).
Time frame: Baseline (T0: Post-induction) and 24 hours postoperatively (T1).
Change in Montreal Cognitive Assessment (MoCA) Score
The MoCA is a 30-point screening tool for detecting cognitive dysfunction. Higher scores indicate better cognitive function (Range: 0-30).
Time frame: Baseline (Preoperative ward visit) and 24 hours postoperatively.
Duration of Target Hypotension
Total time (in minutes) the patient's Mean Arterial Pressure (MAP) is maintained within the target range of 50-65 mmHg.
Time frame: Intraoperative period (from surgical incision to end of surgery, approximately 1-3 hours).
Plan to share: Yes — De-identified individual participant data (IPD) that underlie the results reported in the final publication will be shared upon reasonable request. Data will only be shared for academic, non-commercial purposes to ensure compliance with personal data protection regulations.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Data will become available beginning 6 months and ending 36 months following the publication of the primary research article.
Access criteria: Data will be shared with researchers who provide a methodologically sound research proposal. Requests should be directed to the corresponding author via email. Requestors will be required to sign a data access agreement.
No publications or documents are linked to this record.
Ran from Jul 2026 to primary completion in Sep 2026, 2 months.
Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's 2 months is below that.
Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Feb 2027 → Sep 2026 and completion Mar 2027 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kahramanmaras Sutcu Imam University →